Do you want to read an article? Please log in or register.
A Risk Prediction Model for Mortality Among Smokers in the COPDGene® Study
COPD
RECOMMENDED
Related content
RECOMMENDED
COPD
A Risk Prediction Model for Mortality Among Smokers in the COPDGene® Study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Chronic Obstr Pulm Dis
Strand M, Austin E, Moll M, Pratte KA, Regan EA, Hayden LP, Bhatt SP, Boriek AM, Casaburi R, Silverman EK, Fortis S, Ruczinski I, Koegler H, Rossiter HB, Occhipinti M, Hanania NA, Gebrekristos HT, Lynch DA, Kunisaki KM, Young KA, Sieren JC, Ragland M, Hokanson JE, Lutz SM, Make BJ, Kinney GL, Cho MH, Pistolesi M, DeMeo DL, Sciurba FC, Comellas AP, Diaz AA, Barjaktarevic I, Bowler RP, Kanner RE, Peters SP, Ortega VE, Dransfield MT, Crapo JD
doi: 10.15326/jcopdf.7.4.2020.0146
Interstitial Lung Disease
The ILD-GAP Risk Prediction Model Performs Poorly in Myositis-Associated Interstitial Lung Disease
Respir Med.
Brusca RM, Pinal-Fernandez I, Psoter K, Paik JJ, Albayda J, Mecoli C, Tiniakou E, Mammen AL, Cristopher-Stine L, Danoff SD, Johnson C
doi: 10.1016/j.rmed.
RECOMMENDED
COPD
DNA Methylation is Predictive of Mortality in Current and Former Smokers
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Am J Respir Crit Care Med.
Morrow JD, Make B, Regan E, Han M, Hersh CP, Tal-Singer R, Quackenbush J, Choi AMK, Silverman EK, DeMeo DL
doi: 10.1164/rccm.201902-0439OC.
RECOMMENDED
Interstitial Lung Disease
Mortality risk prediction in amyopathic dermatomyositis associated with interstitial lung disease: the FLAIR model
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Chest.
Lian X, Zou J, Guo Q, Chen S, Lu L, Wang R, Zhou M, Fu Q, Ye Y, Bao C
doi: 10.1016/j.chest.2020.04.057.
Interstitial Lung Disease
Outcomes and mortality prediction model of critically ill adults with acute respiratory failure and interstitial lung disease
Chest.
Gannon W, Lederer DJ, Biscotti M, Javaid A, Patel N, Brodie D, Bacchetta M, Baldwin M
doi: 10.1016/j.chest.2018.01.006.
Pulmonary Fibrosis
Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study
Lancet Respir Med.
Herazo-Maya JD, Sun J, Molyneaux PL, Li Q, Villalba JA, Tzouvelekis A, Lynn H, Juan-Guardela BM, Risquez C, Osorio JC, Yan X, Michel G, Aurelien N, Lindell KO, Klesen MJ, Moffatt MF, Cookson WO, Zhang Y, Garcia JGN, Noth I, Prasse A, Bar-Joseph Z, Gibson KF, Zhao H, Herzog EL, Rosas IO, Maher TM, Kaminski N
doi: 10.1016/
RECOMMENDED
COPD
Estimating the cause-specific relative risks of non-optimal temperature on daily mortality: a two-part modelling approach applied to the Global Burden of Disease Study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lancet
Burkart KG, Brauer M, Aravkin AY, Godwin WW, Hay SI, He J, Iannucci VC, Larson SL, Lim SS, Liu J, Murray CJL, Zheng P, Zhou M, Stanaway JD
doi: 10.1016/S0140-6736(21)01700-1
RECOMMENDED
COPD
Factors influencing decline in quality of life in smokers without airflow obstruction: The COPDGene study
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med.
Parekh TM, Bhatia S, Cherrington A, Kim YI, Lambert A, Iyer A, Regan EA, DeMeo DL, Han M, Dransfield MT
doi: 10.1016/j.rmed.2019.105820.
COPD
Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study
Lancet Respir Med.
Gedebjerg A, Szépligeti SK, Wackerhausen LH, Horváth-Puhó E, Dahl R, Hansen JG, Sørensen HT, Nørgaard M, Lange P, Thomsen RW2
doi: 10.1016/